Related Experiment Video
Updated: Jan 30, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Cancer Care in Crisis: How Subsidy Cuts Affected Immunotherapy Access for Patients With Small Cell Lung Cancer in
Nassar El Assaad1, Muriel Slim1, Joumana Yeretzian2
1Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Purpose:
Lebanon's ongoing economic collapse has severely disrupted the health care system, particularly access to essential cancer therapies. Small cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options and poor prognosis. Immune checkpoint inhibitors (ICIs) have provided modest survival benefits in extensive-stage SCLC (ES-SCLC), but access in resource-limited settings is highly vulnerable to financial instability. In October 2022, Lebanon officially withdrew public subsidies for ICIs, threatening equitable cancer care. This study evaluates the impact of the Ministry of Public Health subsidy withdrawal on access to ICIs and associated outcomes in patients with ES-SCLC.
Materials And Methods:
A mixed-methods study was conducted at Hôtel-Dieu de France (HDF) University Hospital in Beirut. The qualitative component involved a semi-structured interview with the HDF pharmacy to characterize operational challenges. The quantitative component was a retrospective cohort study of patients diagnosed with ES-SCLC from 2019 to 2024. Data included demographics, treatment access, and survival. Analyses included bivariate statistics, Kaplan-Meier survival analysis, and Cox proportional hazards regression.
Results:
The interview identified financial hardship and drug shortages as major barriers. Among 71 patients, 75% did not receive guideline-concordant optimal treatment. Access to ICIs was significantly associated with method of payment (χ2 = 13.8, P = .037) and public insurance coverage (χ2 = 8.6, P = .035). Survival was higher among patients receiving optimal treatment (P = .021), male patients (P = .004), and those treated before subsidy withdrawal (P = .037). In multivariable Cox regression, male gender, optimal treatment, and public insurance were independently associated with improved survival.
Conclusion:
The withdrawal of public subsidies amid Lebanon's economic crisis critically disrupted access to ICIs and contributed to poorer outcomes. Robust financial protection mechanisms are urgently needed to sustain equitable cancer care.
Related Concept Videos
Patient-centered Care
Cancer
Cancer Cell Migration through Invadopodia
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

